During the past decade, Atlanta Heart Specialists, LLC conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 6 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 6 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Atlanta Heart Specialists, LLC" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Bayer" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored, "Amryt Pharma" with 1 trials sponsored and "Analytics For Life" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Atlanta Heart Specialists, LLC" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "GLOCK HEALTH, Science and Research, G.m.b.h." with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Atlanta Heart Specialists, LLC" are "Heart Failure" (3 trials), "Atrial Fibrillation" (2 trials), "Cardiovascular Disease" (2 trials), "Coronary Artery Disease" (2 trials) and "Adverse Effect of MRI on an Implanted Pacemaker" (1 trials). Many other conditions were trialed in "Atlanta Heart Specialists, LLC" in a lesser frequency.

Most popular intervention types in "Atlanta Heart Specialists, LLC" are "Drug" (11 trials), "Device" (2 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Empagliflozin" (2 trials), "Accent MRI system (lead safety)" (1 trials), "Accent MRI system (with MRI scan)" (1 trials) and "Apixaban" (1 trials). Other intervention names were less common.

The vast majority of trials in "Atlanta Heart Specialists, LLC" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Atlanta Heart Specialists, LLC". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Atlanta Heart Specialists, LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Atlanta Heart Specialists, LLC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".

Atlanta Heart Specialists, LLC has several departments that took part in Clinical trials: "Atlanta Heart Specialists, LLC" - 4 trials